IP Verse

Pharmaceutical Composition Containing Poorly-Soluble Basic Medicine - EP3815688

The patent EP3815688 was granted to Chugai Seiyaku Kabushiki Kaisha on Dec 6, 2023. The application was originally filed on Jun 28, 2019 under application number EP19826841A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3815688

CHUGAI SEIYAKU KABUSHIKI KAISHA
Application Number
EP19826841A
Filing Date
Jun 28, 2019
Status
Granted And Under Opposition
Nov 3, 2023
Grant Date
Dec 6, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

SANDOZSep 6, 2024GREINERADMISSIBLE
TEVA PHARMACEUTICALSSep 4, 2024KRAUS & LEDERER PARTGMBBADMISSIBLE

Patent Citations (12) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONJP2009100783
DESCRIPTIONJP4588121B
DESCRIPTIONJP5859712B
DESCRIPTIONJPS4918630B
DESCRIPTIONJPS506987B
DESCRIPTIONWO2015163447
DESCRIPTIONWO2016021707
INTERNATIONAL-SEARCH-REPORTWO2012023597
INTERNATIONAL-SEARCH-REPORTWO2015163448
INTERNATIONAL-SEARCH-REPORTWO2016021707
OPPOSITIONEP2606886
OPPOSITIONEP3135287

Non-Patent Literature (NPL) Citations (23) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- Journal of Crystal Growth, (20040000), vol. 263, pages 480 - 490-
DESCRIPTION- Nature, (20070000), vol. 448, pages 561 - 566-
DESCRIPTION- Neuropsychopharmacology, (20080000), vol. 33, pages 685 - 700-
INTERNATIONAL-SEARCH-REPORT- YAMAMURA, Takahiro, "Effects of automated external lubrication on tablet properties and the stability of eprazinone hydrochloride", Thesis, (20090331), vol. 370, no. 1-2, pages 1 - 7, XP026001800 [A] 1-11
OPPOSITION- A.M. Campeta, "Magnesium Oxide", A.M. Campeta, Raymond C Rowe; Paul J Sheskey; Marian E Quinn (eds.), Handbook of Pharmaceutical Excipients, UK , Pharmaceutical Press , (20090101), pages 400 - 402, ISBN 978-0-85369-792-3, XP009556859-
OPPOSITION- Anonymous, "GENERAL RULES FOR PREPARATIONS", THE JAPANESE PHARMACOPOEIA SEVENTEENTH EDITION, (20160401), pages 7 - 155-157, XP093266605-
OPPOSITION- Bauer Kurt H, Karl-Heinz Frömming , Claus Führer, "Passage ; Bauer I Frömming I Führer Pharmazeutische Technologie Mit Einführung in die Biopharmazie", Bauer I Frömming I Führer Pharmazeutische Technologie Mit Einführung in die Biopharmazie, Stuttgart, Wissenschaftliche Verlagsgesellschaf, (20120101), pages 493 - 496, XP093216241-
OPPOSITION- D11: EXPERIMENTAL REPORT ON THE DISSOLUTION PROPERTIES OF TABLETS ACCORDING TO THE OPPOSED PATENT VS. COMPARATIVE EXAMPLE-
OPPOSITION- D12: EXPERIMENTAL REPORT ON THE DISINTEGRATION PROPERTIES OF TABLETS ACCORDING TO THE OPPOSED PATENT VS. COMPARATIVE EXAMPLE-
OPPOSITION- D14: EUROPEAN MEDICINES AGENCY, DOC. REF.: EMA/CHMP/790261/2018; ALECTINIB HARD CAPSULE 150 MG PRODUCT-SPECIFIC BIOEQUIVALENCE GUIDAN-
OPPOSITION- Peter York, "Chapter 1: The design of dosage forms", PHARMACEUTICS: THE SCIENCE OF DOSAGE FORM DESIGN, Second Edition, Elsevier , (20020101), pages 1 - 12, ISBN 0-443-05517-3, XP009555448-
OPPOSITION- Rowe, Raymond C., "Calcium Carbonate", Handbook of Pharmaceutical Excipients, 6th Edition, London, Chicago, Pharmaceutical Press, American Pharmacists Association, (20090101), page 86, ISBN 9780853697923, XP009557885-
OPPOSITION- Rowe Raymond C., "Magnesium Aluminum Silicate", Rowe Raymond C., Raymond C Rowe; Paul J Sheskey; Marian E Quinn (eds.), Handbook of Pharmaceutical Excipients, UK , Pharmaceutical Press , (20090101), pages 393 - 396, ISBN 978-0-85369-792-3, XP093213698-
OPPOSITION- Rowe Raymond C., "Magnesium Carbonate", Rowe Raymond C., Raymond C Rowe; Paul J Sheskey; Marian E Quinn (eds.), Handbook of Pharmaceutical Excipients, UK , Pharmaceutical Press , (20090101), pages 397 - 400, ISBN 978-0-85369-792-3, XP093213704-
OPPOSITION- Rowe Raymond C., "Magnesium Silicate", Rowe Raymond C., Raymond C Rowe; Paul J Sheskey; Marian E Quinn (eds.), Handbook of Pharmaceutical Excipients, UK , Pharmaceutical Press , (20090101), pages 402 - 403, ISBN 978-0-85369-792-3, XP093213706-
OPPOSITION- Rowe Raymond C., "Meglumine", Rowe Raymond C., Raymond C Rowe; Paul J Sheskey; Marian E Quinn (eds.), Handbook of Pharmaceutical Excipients, UK , Pharmaceutical Press , (20090101), pages 431 - 433, ISBN 978-0-85369-792-3, XP093213710-
OPPOSITION- Rowe Raymond C., "Sodium Bicarbonate", Rowe Raymond C., Raymond C Rowe; Paul J Sheskey; Marian E Quinn (eds.), Handbook of Pharmaceutical Excipients, UK , Pharmaceutical Press , (20090101), pages 629 - 633, ISBN 978-0-85369-792-3, XP093213714-
OPPOSITION- Seiyaku Chugai, Kaisha Kabushiki, "COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE INVESTIGATION OF BIOEQUIVALENCE", European Medicines Agency, (20100120), pages 1 - 27, XP093266602-
OPPOSITION- Bhattachar Shobha N., Risley Donald S., Werawatganone Pornpen, Aburub Aktham, "Weak bases and formation of a less soluble lauryl sulfate salt/complex in sodium lauryl sulfate (SLS) containing media", International Journal of Pharmaceutics, (20110601), vol. 412, no. 1-2, doi:10.1016/j.ijpharm.2011.04.018, ISSN 0378-5173, pages 95 - 98, XP093213241
OPPOSITION- Huang Zongyun; Parikh Shuchi; Fish William P., "Interactions between a poorly soluble cationic drug and sodium dodecyl sulfate in dissolution medium and their impact onin vitrodissolution behavior", International Journal of Pharmaceutics, Elsevier, (20171120), vol. 535, no. 1, doi:10.1016/j.ijpharm.2017.10.063, ISSN 0378-5173, pages 350 - 359, XP085328538
OPPOSITION- Parind Mahendrakumar Desai, Celine Valeria Liew, Paul Wan Sia Heng, "Review of Disintegrants and the Disintegration Phenomena", Journal of Pharmaceutical Sciences, Wiley, United States, United States, (20160901), vol. 105, no. 9, doi:10.1016/j.xphs.2015.12.019, ISSN 0022-3549, pages 2545 - 2555, XP055607494
OPPOSITION- Madlool Dheyaa Tohma, Al-Ani Israa, Ata Tha’er, Dayyih Wael Abu, "Solubility, pH-Solubility Profile, pH-Rate Profile, and Kinetic Stability of the Tyrosine Kinase Inhibitor, Alectinib", Pharmaceuticals, M D P I AG, CH, CH , (20240601), vol. 17, no. 6, doi:10.3390/ph17060776, ISSN 1424-8247, pages 776 - 12, XP093213717
SEARCH- JOHN ROJAS ET AL, "Functional Assessment of Four Types of Disintegrants and their Effect on the Spironolactone Release Properties", AAPS PHARMSCITECH, SPRINGER NEW YORK LLC, US, (20120817), vol. 13, no. 4, doi:10.1208/S12249-012-9835-Y, ISSN 1530-9932, pages 1054 - 1062, XP035147986 [A] 1-11 * abstract *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents